A metabolic perspective of late onset Alzheimer's disease - ScienceDirect
Old School Gospel Concert Fundraiser Benefitting the Kosten Foundation and Pancreatic Cancer Research - Herb Kosten Foundation
Frontiers | Mouse Models of Alzheimer's Disease
Molecular mechanisms in Alzheimer's disease and related potential treatments such as structural target convergence of antibodies and simple organic molecules - ScienceDirect
IJMS | Free Full-Text | β-Secretase-1: In Silico Drug Reposition for Alzheimer’s Disease
Advances and applications of fluids biomarkers in diagnosis and therapeutic targets of Alzheimer's disease - Xu - CNS Neuroscience & Therapeutics - Wiley Online Library
Frontiers | Neurotechnological Approaches to the Diagnosis and Treatment of Alzheimer's Disease
Treatment Combinations for Alzheimer's Disease: Current and Future Pharmacotherapy Options - IOS Press
Ketogen kost för att förebygga och behandla Alzheimers - Diet Doctor
Frontiers | Targeting Amyloidogenic Processing of APP in Alzheimer's Disease
Migraine Diagnoses Positively Associated with All-Cause Dementia and Alzheimer's Disease in Women in the UK | Journal of Alzheimer's Disease
Frontiers | Insulin Resistance in Alzheimer's Disease
Therapy for Alzheimer's disease: Missing targets and functional markers? - ScienceDirect
IJMS | Free Full-Text | Natural Products Targeting Amyloid Beta in Alzheimer's Disease
Kaempferol as a therapeutic agent in Alzheimer's disease: Evidence from preclinical studies - ScienceDirect
Implications of Successful Symptomatic Treatment in Parkinson's Disease for Therapeutic Strategies of Alzheimer's Disease | ACS Chemical Neuroscience
Advances in Modeling Alzheimer's Disease In Vitro - Sharma - 2021 - Advanced NanoBiomed Research - Wiley Online Library
Role of microbial dysbiosis in the pathogenesis of Alzheimer's disease - ScienceDirect
Combinatorial Treatment Using Umbilical Cord Perivascular Cells and Aβ Clearance Rescues Vascular Function Following Transient Hypertension in a Rat Model of Alzheimer Disease | Hypertension
Current and emerging avenues for Alzheimer's disease drug targets - Loera‐Valencia - 2019 - Journal of Internal Medicine - Wiley Online Library
Treatment with glucagon‐like peptide‐1 receptor agonists and incidence of dementia: Data from pooled double‐blind randomized controlled trials and nationwide disease and prescription registers - Nørgaard - 2022 - Alzheimer's & Dementia: Translational
IJMS | Free Full-Text | Therapeutic Targeting Strategies for Early- to Late-Staged Alzheimer's Disease
Cells | Free Full-Text | Neuroprotective Natural Products for Alzheimer's Disease
